Cargando…

Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases

BACKGROUND: Salvage of recurrent previously irradiated brain metastases (rBrM) is a significant challenge. Resection without adjuvant re-irradiation is associated with a high local failure rate, while reirradiation only partially reduces failure but is associated with greater radiation necrosis risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Imber, Brandon S., Young, Robert J., Beal, Kathryn, Reiner, Anne S., Giantini-Larsen, Alexandra M., Krebs, Simone, Yang, Jonathan T., Aramburu-Nunez, David, Cohen, Gil’ad N., Brennan, Cameron, Tabar, Viviane, Moss, Nelson S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328626/
https://www.ncbi.nlm.nih.gov/pubmed/35896906
http://dx.doi.org/10.1007/s11060-022-04101-9
_version_ 1784757764496556032
author Imber, Brandon S.
Young, Robert J.
Beal, Kathryn
Reiner, Anne S.
Giantini-Larsen, Alexandra M.
Krebs, Simone
Yang, Jonathan T.
Aramburu-Nunez, David
Cohen, Gil’ad N.
Brennan, Cameron
Tabar, Viviane
Moss, Nelson S.
author_facet Imber, Brandon S.
Young, Robert J.
Beal, Kathryn
Reiner, Anne S.
Giantini-Larsen, Alexandra M.
Krebs, Simone
Yang, Jonathan T.
Aramburu-Nunez, David
Cohen, Gil’ad N.
Brennan, Cameron
Tabar, Viviane
Moss, Nelson S.
author_sort Imber, Brandon S.
collection PubMed
description BACKGROUND: Salvage of recurrent previously irradiated brain metastases (rBrM) is a significant challenge. Resection without adjuvant re-irradiation is associated with a high local failure rate, while reirradiation only partially reduces failure but is associated with greater radiation necrosis risk. Salvage resection plus Cs131 brachytherapy may offer dosimetric and biologic advantages including improved local control versus observation, with reduced normal brain dose versus re-irradiation, however data are limited. METHODS: A prospective registry of consecutive patients with post-stereotactic radiosurgery (SRS) rBrM undergoing resection plus implantation of collagen-matrix embedded Cs131 seeds (GammaTile, GT Medical Technologies) prescribed to 60 Gy at 5 mm from the cavity was analyzed. RESULTS: Twenty patients underwent 24 operations with Cs131 implantation in 25 tumor cavities. Median maximum preoperative diameter was 3.0 cm (range 1.1–6.3). Gross- or near-total resection was achieved in 80% of lesions. A median of 16 Cs131 seeds (range 6–30), with a median air-kerma strength of 3.5 U/seed were implanted. There was one postoperative wound dehiscence. With median follow-up of 1.6 years for survivors, two tumors recurred (one in-field, one marginal) resulting in 8.4% 1-year progression incidence (95%CI = 0.0–19.9). Radiographic seed settling was identified in 7/25 cavities (28%) 1.9–11.7 months post-implantation, with 1 case of distant migration (4%), without clinical sequelae. There were 8 cases of radiation necrosis, of which 4 were symptomatic. CONCLUSIONS: With > 1.5 years of follow-up, intraoperative brachytherapy with commercially available Cs131 implants was associated with favorable local control and toxicity profiles. Weak correlation between preoperative tumor geometry and implanted tiles highlights a need to optimize planning criteria. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-022-04101-9.
format Online
Article
Text
id pubmed-9328626
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-93286262022-07-28 Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases Imber, Brandon S. Young, Robert J. Beal, Kathryn Reiner, Anne S. Giantini-Larsen, Alexandra M. Krebs, Simone Yang, Jonathan T. Aramburu-Nunez, David Cohen, Gil’ad N. Brennan, Cameron Tabar, Viviane Moss, Nelson S. J Neurooncol Research BACKGROUND: Salvage of recurrent previously irradiated brain metastases (rBrM) is a significant challenge. Resection without adjuvant re-irradiation is associated with a high local failure rate, while reirradiation only partially reduces failure but is associated with greater radiation necrosis risk. Salvage resection plus Cs131 brachytherapy may offer dosimetric and biologic advantages including improved local control versus observation, with reduced normal brain dose versus re-irradiation, however data are limited. METHODS: A prospective registry of consecutive patients with post-stereotactic radiosurgery (SRS) rBrM undergoing resection plus implantation of collagen-matrix embedded Cs131 seeds (GammaTile, GT Medical Technologies) prescribed to 60 Gy at 5 mm from the cavity was analyzed. RESULTS: Twenty patients underwent 24 operations with Cs131 implantation in 25 tumor cavities. Median maximum preoperative diameter was 3.0 cm (range 1.1–6.3). Gross- or near-total resection was achieved in 80% of lesions. A median of 16 Cs131 seeds (range 6–30), with a median air-kerma strength of 3.5 U/seed were implanted. There was one postoperative wound dehiscence. With median follow-up of 1.6 years for survivors, two tumors recurred (one in-field, one marginal) resulting in 8.4% 1-year progression incidence (95%CI = 0.0–19.9). Radiographic seed settling was identified in 7/25 cavities (28%) 1.9–11.7 months post-implantation, with 1 case of distant migration (4%), without clinical sequelae. There were 8 cases of radiation necrosis, of which 4 were symptomatic. CONCLUSIONS: With > 1.5 years of follow-up, intraoperative brachytherapy with commercially available Cs131 implants was associated with favorable local control and toxicity profiles. Weak correlation between preoperative tumor geometry and implanted tiles highlights a need to optimize planning criteria. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-022-04101-9. Springer US 2022-07-27 2022 /pmc/articles/PMC9328626/ /pubmed/35896906 http://dx.doi.org/10.1007/s11060-022-04101-9 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, corrected publication 2022Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research
Imber, Brandon S.
Young, Robert J.
Beal, Kathryn
Reiner, Anne S.
Giantini-Larsen, Alexandra M.
Krebs, Simone
Yang, Jonathan T.
Aramburu-Nunez, David
Cohen, Gil’ad N.
Brennan, Cameron
Tabar, Viviane
Moss, Nelson S.
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
title Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
title_full Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
title_fullStr Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
title_full_unstemmed Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
title_short Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
title_sort salvage resection plus cesium-131 brachytherapy durably controls post-srs recurrent brain metastases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328626/
https://www.ncbi.nlm.nih.gov/pubmed/35896906
http://dx.doi.org/10.1007/s11060-022-04101-9
work_keys_str_mv AT imberbrandons salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT youngrobertj salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT bealkathryn salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT reinerannes salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT giantinilarsenalexandram salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT krebssimone salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT yangjonathant salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT aramburununezdavid salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT cohengiladn salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT brennancameron salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT tabarviviane salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases
AT mossnelsons salvageresectionpluscesium131brachytherapydurablycontrolspostsrsrecurrentbrainmetastases